Pediatric Pharmacoepidemiology

(271) Interferon-beta exposure in-utero and the risk of infections

(272) Changes in Pediatric Emergency Department Visits and Hospitalizations for Unintentional Exposures to Oral Prescription Medications in the United States, 2010-2021

(273) Validation of ICD-9- and ICD-10-based Diagnostic Algorithms for Juvenile Idiopathic Arthritis within a Large U.S. Commercial Claims Database

(275) Sex-specific prevalences of psychotropic medication in pediatric populations from DK and US: 2010-2020

(276) Medical cannabis related drug-drug interactions in children: A systematic review

(277) Sociodemographic and birth characteristics associated with initiation of methylphenidate treatment in children: a nationwide study from 2015 to 2022

(278) Utilisation and safety of Glycopyrronium Bromide 1mg/5ml oral solution for sialorrhoea in the paediatric population in the UK: Interim results from a non-interventional post authorisation safety study

(279) First-Line Treatments for Infantile Spasms: A GRADE Analysis of Umbrella Review of Systematic Reviews and Meta-Analyses

(280) Comparison of presepsin and interleukin 6 for the diagnosis of neonatal sepsis: a systematic review and meta-analysis

(282) Pediatric observational effectiveness evaluation studies in the EU PAS Register: What can we learn from study characteristics?

(284) Trend analysis of medication label prediction model based on real-world pediatric drug database

(285) Real-world Data Evaluating Safety, Effectiveness and Dosing of Dalteparin for the Treatment of Venous Thromboembolism (VTE) in Neonates Aged 0 to 28 days

(286) Accuracy of ICD-10 Diagnosis Codes for Identifying Influenza Illness Among Children in the Emergency Department and Hospital Settings

(287) Assessing neonatal outcome misclassification using mother-infant dyad claims